Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Risk Factors for MERS-CoV Seropositivity among Animal Market and Slaughterhouse Workers, Abu Dhabi, United Arab Emirates, 2014-2017.

Khudhair A, Killerby ME, Al Mulla M, Abou Elkheir K, Ternanni W, Bandar Z, Weber S, Khoury M, Donnelly G, Al Muhairi S, Khalafalla AI, Trivedi S, Tamin A, Thornburg NJ, Watson JT, Gerber SI, Al Hosani F, Hall AJ.

Emerg Infect Dis. 2019 May;25(5):927-935. doi: 10.3201/eid2505.181728.

2.

Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia.

Al-Abdely HM, Midgley CM, Alkhamis AM, Abedi GR, Lu X, Binder AM, Alanazi KH, Tamin A, Banjar WM, Lester S, Abdalla O, Dahl RM, Mohammed M, Trivedi S, Algarni HS, Sakthivel SK, Algwizani A, Bafaqeeh F, Alzahrani A, Alsharef AA, Alhakeem RF, Jokhdar HAA, Ghazal SS, Thornburg NJ, Erdman DD, Assiri AM, Watson JT, Gerber SI.

Emerg Infect Dis. 2019 Apr;25(4):753-766. doi: 10.3201/eid2504.181595.

3.

Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses.

Trivedi SU, Miao C, Sanchez JE, Caidi H, Tamin A, Haynes L, Thornburg NJ.

Sci Rep. 2019 Feb 4;9(1):1390. doi: 10.1038/s41598-018-37747-5.

4.

Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia, 2017.

Alanazi KH, Killerby ME, Biggs HM, Abedi GR, Jokhdar H, Alsharef AA, Mohammed M, Abdalla O, Almari A, Bereagesh S, Tawfik S, Alresheedi H, Alhakeem RF, Hakawi A, Alfalah H, Amer H, Thornburg NJ, Tamin A, Trivedi S, Tong S, Lu X, Queen K, Li Y, Sakthivel SK, Tao Y, Zhang J, Paden CR, Al-Abdely HM, Assiri AM, Gerber SI, Watson JT.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):79-88. doi: 10.1017/ice.2018.290.

PMID:
30595141
5.

Infectious MERS-CoV Isolated From a Mildly Ill Patient, Saudi Arabia.

Al-Abdely HM, Midgley CM, Alkhamis AM, Abedi GR, Tamin A, Binder AM, Alanazi K, Lu X, Abdalla O, Sakthivel SK, Mohammed M, Queen K, Algarni HS, Li Y, Trivedi S, Algwizani A, Alhakeem RF, Thornburg NJ, Tong S, Ghazal SS, Erdman DD, Assiri AM, Gerber SI, Watson JT.

Open Forum Infect Dis. 2018 May 15;5(6):ofy111. doi: 10.1093/ofid/ofy111. eCollection 2018 Jun.

6.

Multihospital Outbreak of a Middle East Respiratory Syndrome Coronavirus Deletion Variant, Jordan: A Molecular, Serologic, and Epidemiologic Investigation.

Payne DC, Biggs HM, Al-Abdallat MM, Alqasrawi S, Lu X, Abedi GR, Haddadin A, Iblan I, Alsanouri T, Al Nsour M, Sheikh Ali S, Rha B, Trivedi SU, Rasheed MAU, Tamin A, Lamers MM, Haagmans BL, Erdman DD, Thornburg NJ, Gerber SI.

Open Forum Infect Dis. 2018 Apr 28;5(5):ofy095. doi: 10.1093/ofid/ofy095. eCollection 2018 May.

7.

Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts-Abu Dhabi, United Arab Emirates.

Al Hosani FI, Kim L, Khudhair A, Pham H, Al Mulla M, Al Bandar Z, Pradeep K, Elkheir KA, Weber S, Khoury M, Donnelly G, Younis N, El Saleh F, Abdalla M, Imambaccus H, Haynes LM, Thornburg NJ, Harcourt JL, Miao C, Tamin A, Hall AJ, Russell ES, Harris AM, Kiebler C, Mir RA, Pringle K, Alami NN, Abedi GR, Gerber SI.

Clin Infect Dis. 2019 Jan 18;68(3):409-418. doi: 10.1093/cid/ciy503.

PMID:
29905769
8.

The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.

Harcourt JL, Rudoler N, Tamin A, Leshem E, Rasis M, Giladi M, Haynes LM.

Zoonoses Public Health. 2018 Sep;65(6):749-754. doi: 10.1111/zph.12482. Epub 2018 May 31.

9.

Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection.

Trivedi S, Miao C, Al-Abdallat MM, Haddadin A, Alqasrawi S, Iblan I, Nsour MA, Alsanouri T, Ali SS, Rha B, Gerber SI, Payne DC, Tamin A, Thornburg NJ.

J Med Virol. 2018 Feb;90(2):367-371. doi: 10.1002/jmv.24948. Epub 2017 Sep 26.

10.

Conveyance Contact Investigation for Imported Middle East Respiratory Syndrome Cases, United States, May 2014.

Lippold SA, Objio T, Vonnahme L, Washburn F, Cohen NJ, Chen TH, Edelson PJ, Gulati R, Hale C, Harcourt J, Haynes L, Jewett A, Jungerman R, Kohl KS, Miao C, Pesik N, Regan JJ, Roland E, Schembri C, Schneider E, Tamin A, Tatti K, Alvarado-Ramy F.

Emerg Infect Dis. 2017 Sep;23(9):1585-1589. doi: 10.3201/eid2309.170365.

11.

Antibodies Against Henipa-Like Viruses in Brazilian Bats.

de Araujo J, Lo MK, Tamin A, Ometto TL, Thomazelli LM, Nardi MS, Hurtado RF, Nava A, Spiropoulou CF, Rota PA, Durigon EL.

Vector Borne Zoonotic Dis. 2017 Apr;17(4):271-274. doi: 10.1089/vbz.2016.2051. Epub 2017 Jan 19.

PMID:
28103156
12.

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.

Payne DC, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M, Alsanouri T, Ali SS, Harcourt J, Miao C, Tamin A, Gerber SI, Haynes LM, Al Abdallat MM.

Emerg Infect Dis. 2016 Oct;22(10):1824-6. doi: 10.3201/eid2210.160706. Epub 2016 Oct 15.

13.

Epidemiology of a Novel Recombinant Middle East Respiratory Syndrome Coronavirus in Humans in Saudi Arabia.

Assiri AM, Midgley CM, Abedi GR, Bin Saeed A, Almasri MM, Lu X, Al-Abdely HM, Abdalla O, Mohammed M, Algarni HS, Alhakeem RF, Sakthivel SK, Nooh R, Alshayab Z, Alessa M, Srinivasamoorthy G, AlQahtani SY, Kheyami A, HajOmar WH, Banaser TM, Esmaeel A, Hall AJ, Curns AT, Tamin A, Alsharef AA, Erdman D, Watson JT, Gerber SI.

J Infect Dis. 2016 Sep 1;214(5):712-21. doi: 10.1093/infdis/jiw236. Epub 2016 Jun 14.

14.

Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description.

Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, Al Nsour M, Iblan I, Jarour N, Farag NH, Haddadin A, Al-Sanouri T, Tamin A, Harcourt JL, Kuhar DT, Swerdlow DL, Erdman DD, Pallansch MA, Haynes LM, Gerber SI; Jordan MERS-CoV Investigation Team.

Clin Infect Dis. 2014 Nov 1;59(9):1225-33. doi: 10.1093/cid/ciu359. Epub 2014 May 14.

15.

Current status of diagnostic methods for henipavirus.

Tamin A, Rota PA.

Dev Biol (Basel). 2013;135:139-45. doi: 10.1159/000189236. Epub 2013 May 14.

PMID:
23689891
16.

Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.

Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, Beeler JA, Audet S, Kiehl B, Nandy R, Tamin A, Bellini WJ.

J Infect Dis. 2011 Jul;204 Suppl 1:S549-58. doi: 10.1093/infdis/jir106.

PMID:
21666212
17.

Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein.

Zhong L, Haynes L, Struble EB, Tamin A, Virata-Theimer ML, Zhang P.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):1056-60. doi: 10.1016/j.bbrc.2009.10.115. Epub 2009 Oct 25.

PMID:
19861118
18.

Development of a neutralization assay for Nipah virus using pseudotype particles.

Tamin A, Harcourt BH, Lo MK, Roth JA, Wolf MC, Lee B, Weingartl H, Audonnet JC, Bellini WJ, Rota PA.

J Virol Methods. 2009 Sep;160(1-2):1-6. doi: 10.1016/j.jviromet.2009.02.025. Epub 2009 Mar 9.

19.

Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells.

Lo MK, Harcourt BH, Mungall BA, Tamin A, Peeples ME, Bellini WJ, Rota PA.

J Gen Virol. 2009 Feb;90(Pt 2):398-404. doi: 10.1099/vir.0.007294-0.

PMID:
19141449
20.

Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.

Sleeman K, Stein DA, Tamin A, Reddish M, Iversen PL, Rota PA.

Virus Res. 2009 Mar;140(1-2):49-56. doi: 10.1016/j.virusres.2008.10.018. Epub 2009 Jan 6.

PMID:
19059443
21.

Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway.

Sui J, Aird DR, Tamin A, Murakami A, Yan M, Yammanuru A, Jing H, Kan B, Liu X, Zhu Q, Yuan QA, Adams GP, Bellini WJ, Xu J, Anderson LJ, Marasco WA.

PLoS Pathog. 2008 Nov;4(11):e1000197. doi: 10.1371/journal.ppat.1000197. Epub 2008 Nov 7.

22.

Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses.

Liniger M, Zuniga A, Tamin A, Azzouz-Morin TN, Knuchel M, Marty RR, Wiegand M, Weibel S, Kelvin D, Rota PA, Naim HY.

Vaccine. 2008 Apr 16;26(17):2164-74. doi: 10.1016/j.vaccine.2008.01.057. Epub 2008 Feb 22.

PMID:
18346823
23.

Maternal antibody inhibits both cellular and humoral immunity in response to measles vaccination at birth.

Premenko-Lanier M, Hodge G, Rota P, Tamin A, Bellini W, McChesney M.

Virology. 2006 Jul 5;350(2):429-32. Epub 2006 Mar 29.

24.

Genetic characterization of Nipah virus, Bangladesh, 2004.

Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, Gurley ES, Breiman RF, Bellini WJ, Rota PA.

Emerg Infect Dis. 2005 Oct;11(10):1594-7.

25.

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.

Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ.

J Virol Methods. 2005 Sep;128(1-2):21-8.

PMID:
15885812
26.

SARS-coronavirus replication in human peripheral monocytes/macrophages.

Yilla M, Harcourt BH, Hickman CJ, McGrew M, Tamin A, Goldsmith CS, Bellini WJ, Anderson LJ.

Virus Res. 2005 Jan;107(1):93-101.

PMID:
15567038
27.

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.

Sui J, Li W, Murakami A, Tamin A, Matthews LJ, Wong SK, Moore MJ, Tallarico AS, Olurinde M, Choe H, Anderson LJ, Bellini WJ, Farzan M, Marasco WA.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41.

28.

Effects of a SARS-associated coronavirus vaccine in monkeys.

Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD, Bellini WJ, Barratt-Boyes S, Gambotto A.

Lancet. 2003 Dec 6;362(9399):1895-6.

PMID:
14667748
29.

Characterization of a novel coronavirus associated with severe acute respiratory syndrome.

Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Günther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ.

Science. 2003 May 30;300(5624):1394-9. Epub 2003 May 1.

30.

Functional properties of the fusion and attachment glycoproteins of Nipah virus.

Tamin A, Harcourt BH, Ksiazek TG, Rollin PE, Bellini WJ, Rota PA.

Virology. 2002 Apr 25;296(1):190-200.

31.

Molecular characterization of the polymerase gene and genomic termini of Nipah virus.

Harcourt BH, Tamin A, Halpin K, Ksiazek TG, Rollin PE, Bellini WJ, Rota PA.

Virology. 2001 Aug 15;287(1):192-201.

32.

Molecular biology of Hendra and Nipah viruses.

Wang L, Harcourt BH, Yu M, Tamin A, Rota PA, Bellini WJ, Eaton BT.

Microbes Infect. 2001 Apr;3(4):279-87. Review.

PMID:
11334745
33.

Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.

Zhu Yd, Rota P, Wyatt L, Tamin A, Rozenblatt S, Lerche N, Moss B, Bellini W, McChesney M.

Virology. 2000 Oct 10;276(1):202-13.

34.

Molecular characterization of Nipah virus, a newly emergent paramyxovirus.

Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, Rota PA.

Virology. 2000 Jun 5;271(2):334-49.

35.

Nipah virus: a recently emergent deadly paramyxovirus.

Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, Olson J, Field H, Daniels P, Ling AE, Peters CJ, Anderson LJ, Mahy BW.

Science. 2000 May 26;288(5470):1432-5.

36.

New genetic group of measles virus isolated in the People's Republic of China.

Xu W, Tamin A, Rota JS, Zhang L, Bellini WJ, Rota PA.

Virus Res. 1998 Apr;54(2):147-56.

PMID:
9696123
37.

Antigenic analysis of current wild type and vaccine strains of measles virus.

Tamin A, Rota PA, Wang ZD, Heath JL, Anderson LJ, Bellini WJ.

J Infect Dis. 1994 Oct;170(4):795-801.

PMID:
7930720
38.

Further analyses of the orthopoxviruses volepox virus and raccoon poxvirus.

Knight JC, Goldsmith CS, Tamin A, Regnery RL, Regnery DC, Esposito JJ.

Virology. 1992 Sep;190(1):423-33.

PMID:
1529541
40.
41.

Supplemental Content

Support Center